For Australian Clinicians

Liver Elastography for Australian Clinicians

Elastography Australia is built for real-world liver assessment in Australian practice. It combines guided elastography, strong obese-patient performance, and a lower capital barrier for clinics that want better access to liver staging without depending on tertiary centres.

Commercial Snapshot

Why clinics are switching to guided elastography

Around 6 million Australians are estimated to be living with MAFLD, increasing second-line testing demand.

Private scan fees commonly sit in the $195-$250 range, supporting a clear service-line business case.

Comparative research cites 33-second median exam times for Elastography Australia versus 47 seconds for FibroScan.

A single universal probe removes the workflow friction of S, M, and XL probe switching.

Included With Every Deployment
  • Device setup, operator training, and onboarding support
  • Single-probe workflow designed for day-to-day clinical use
  • Service guidance, workflow planning, and reporting support
  • Commercial advice around ROI, patient demand, and referral positioning
Open ROI Calculator

Future Verticals

Built to expand into more clinical audiences

Hepatologists
Endocrinologists
Bariatric surgeons
Practice managers
Private hospitals
Community health services